BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 10298700)

  • 1. Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance.
    Cackowski A
    J Health Hosp Law; 1996; 29(2):121-4. PubMed ID: 10160175
    [No Abstract]   [Full Text] [Related]  

  • 2. Review boards: a system 'in jeopardy'?
    Marshall E
    Science; 1998 Jun; 280(5371):1830-1. PubMed ID: 9669930
    [No Abstract]   [Full Text] [Related]  

  • 3. Guide to decision-making in institutional review of proposals for human experimentation: commentary.
    George R
    Man Med; 1978; 3(3):210-2. PubMed ID: 10316737
    [No Abstract]   [Full Text] [Related]  

  • 4. Institutional review boards and bioethics committees: their role in ensuring ethical home care research.
    Cary AH
    Home Care Econ; 1987; 1(4):113-8. PubMed ID: 10285378
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of human subjects in experimentation. Institutional review boards: purposes, protocols, legal responsibilities.
    Knepper JD
    J Am Med Rec Assoc (1980); 1982 Oct; 53(5):97-101. PubMed ID: 10298700
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for new rules on human subjects research?
    Dresser R
    Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
    [No Abstract]   [Full Text] [Related]  

  • 8. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 9. The ethical analysis of risk.
    Weijer C
    J Law Med Ethics; 2000; 28(4):344-61. PubMed ID: 11317427
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining and describing benefit appropriately in clinical trials.
    King NM
    J Law Med Ethics; 2000; 28(4):332-43. PubMed ID: 11317426
    [No Abstract]   [Full Text] [Related]  

  • 11. Dealing with conflicts of interest in biomedical research: IRB oversight as the next best solution to the abolitionist approach.
    Goldner JA
    J Law Med Ethics; 2000; 28(4):379-404. PubMed ID: 11317429
    [No Abstract]   [Full Text] [Related]  

  • 12. The ethics of clinical trials: a child's view.
    Rosato J
    J Law Med Ethics; 2000; 28(4):362-78. PubMed ID: 11317428
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.